CE19 - Technologies pour la santé 2021

Towards a radical paradigm shift to overcome presbyopia – PRESB-INNOV-US

Submission summary

Presbyopia is the loss of accommodation affecting any individual after the age of 45 and preventing close reading. Although its consequences have been known and corrected by converging glasses since antiquity, biological aging, which modifies the biomechanics of the lens and makes it lose its flexibility, has only recently been understood. To date, no one has developed a treatment that restores the natural biomechanical properties of the aging crystalline lens. The expertise in focused ultrasound applied to ophthalmology is a very strong point of our territory. Also, by bringing together 2 laboratories and 2 industrial partners with major scientific expertise in ophthalmology, ultrasound, cell biology, biochemistry, optics, biomechanics and engineering, we are equipped to meet this ambitious challenge through PRESB-INNOV-US: moving towards a radical paradigm shift to overcome (finally)presbyopia.

Project coordination

Gilles THURET (Biologie, Ingénierie et Imagerie de la Greffe de Cornée - EA 2521)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

LabTAU LABORATOIRE APPLICATIONS THERAPEUTIQUES DES ULTRASONS
KEJAKO KEJAKO
BIIGC Biologie, Ingénierie et Imagerie de la Greffe de Cornée - EA 2521
QLM Quantel Medical

Help of the ANR 510,117 euros
Beginning and duration of the scientific project: December 2021 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter